Recruiting the NFL: Your Next Big Opportunity?


By Mark D. Uehling Bio-IT World

COMMENTARY |  ESPN bores us--we hear enough about lab tests, drugs and false positives at the office, thank you very much. But early this year, a sports story by the Scripps Howard News Service has not received much attention. Journalist Thomas Hargrove, based in Washington, D.C., has analyzed obesity in the National Football League (NFL). We ourselves only found his article quite belatedly.

Some of Hargrove's data came from a retired pollster, David Neft, who maintained his own records about nearly 4,000 NFL players. Some 125 of the players born in the past 50 years are no longer alive and have conclusive causes of death.

Fifty percent of recently departed NFL players were obese while they were playing the game. Of the NFL players who were obese, 28 percent died before their 50th birthdays. A comparison to 2,403 professional baseball players was fascinating: football players are more than twice as likely to die before the age of 50.

Is this an opportunity, or is this an opportunity? How many clinical trials are unable to find enough patients? The NFL could step up here. Hargrove's work shows that 56 percent of the players in the NFL are now obese. (In 1985, the percentage was 44 percent.) Offensive tackles, on average, now weigh an average of 313 lbs., from an average of 281 lbs. 20 years ago. These guys are big.

A deal with a major drug company or, preferably, the industry as a whole could reinforce the progressive, kid-friendly image of the NFL. Trials in obesity, in diabetes, in bariatric surgery--there are plenty of off-season jobs for the big men of the NFL. Best of all, the players could continue to follow their usual diet all year long, or even eat that second steak, a third baked potato.

As a league, the NFL could offer a ready-made, disciplined group of athletes with charisma and built-in media appeal. We can imagine public service ads with mountain-sized players soberly advising that all football fans consider volunteering for trials.

For the athletes, it could be a wonderful opportunity to study, for the first time, something called science. This vital topic is not taught in every high school or college in the land any more. Giving every NFL player some exposure to science would be good for the sport and good for science. There is no question the NFL players have to care about their health to play the game as well as they do.

Yes, the competitive juices of other sports might flare up. They too might want to participate in a clinical trial. Tobacco-chewing baseball players could be excellent candidates for trials studying dental issues or cancers of the mouth. Hockey players and life-long head injuries could be another match. Cyclists and hormone replacement therapy? Boxers and Parkinson's disease? The opportunity list is endless when it comes to professional sports and clinical trials.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

isilon white paper

“Storage for Science – Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments” sponsored by Isilon
Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics. Determining how best to manage those data stores has become a significant challenge for Researchers and IT Pros alike.

This paper is intended to:

  • Provide guidance on the many storage requirements common to Life Science research;
  • Explain the evolution of modern storage architectures;
  • Summarize the major data storage architectures currently in use.

Additionally, it will present the Isilon IQ clustered storage product as a strong and flexible solution to those needs. Download now



definiens briefingon-76Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



metaminer image(1)

MetaMiner™ Cystic Fibrosis Report,  Sponsored by GeneGo
This paper discusses the MetaMiner™ (CF) data analysis platform for a broad range of CF researchers designed to: 1. Easily assemble important biological and chemical experimental data available today in cystic fibrosis research. 2. Visualize key mechanisms leading to the disease through pathway maps and network models 3. Provide the CF community a “one stop shop” tool for uploading and analyzing experimental data in a disease-centered interface.  Download now 



Life Science Webcasts & Podcasts

Storage for Science
Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments

Sponsored by Isilon

Isilon webcast1

Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics environments. Determining how best to manage those data stores has become a significant challenge for the Researchers and IT Professionals that support them.

This webcast is intended to: 

  • Provide guidance on the many storage requirements common to Life Science research; 
  • Explain the evolution of modern data storage architectures; 
  • Summarize the major data storage architectures currently in use;
  • Present the Isilon IQ clustered storage product as a strong and flexible solution to those needs.

    Download this webcast

More Podcasts

Job Openings

Isilon Systems ~ Senior Marketing Communications Manager
Isilon Systems is the worldwide leader in clustered storage systems and software for digital content and unstructured data. We seek an experienced marketing communications professional/writer expert in creating and delivering effective and persuasive business communications. The ideal candidate can think at the strategic and conceptual level and act, simultaneously, as a highly-effective and productive individual contributor. The position is based in Seattle, WA. For additional information click here:
 

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD 

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125 or via email to bio-itworld@theygsgroup.com.